<DOC>
	<DOCNO>NCT01227590</DOCNO>
	<brief_summary>The study conduct evaluate whether African potato , herbal medicine , use together anti-HIV medicine without affect amount anti-HIV medicine blood . African potato African herbal medicine widely use Africa , particularly sub-Saharan Africa . Although proven , believe help boost immune system . Similar study do herbal medicine especially use develop country . In case , herbal treatment affect blood level medicine medicine use together . This study measure effect African potato lopinavir/ritonavir ( KaletraÂ® ) , common anti-HIV medicine . Lopinavir/ritonavir approve United States Food Drug Administration ( FDA ) . The information obtain study tell u African potato anti-HIV treatment use together treat HIV infect patient Africa resource poor region .</brief_summary>
	<brief_title>Pharmacokinetic Interactions Between Herbal Medicine ( African Potato ) Antiretroviral Agents ( Lopinavir/Ritonavir )</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Anti-Retroviral Agents</mesh_term>
	<criteria>Absence HIV infection prior study entry . Male female age 1860 able provide inform consent . Subject within 20 % ( +/ ) ideal body weight must weigh least 550kg Healthy subject without evidence acute chronic illness include diabetes , hypertension , CAD , psychiatric illness , renal hepatic impairment . Screening laboratory test normal deem clinically significant study physician Female subject childbearing potential must pregnant lactating , must negative pregnancy test screening must practice adequate method birth control . Acceptable method birth control include use intrauterine device ( IUD ) , oral , implanted injected contraceptive , barrier method spermicide . Subjects must sign informed consent complies US Regulations ( US 21 CFR 50 ) International Conference Harmonization ( ICH ) guideline prior undergo studyrelated procedure . Subjects agree abstain consume grapefruit juice least 48 hour prior dose throughout study period last blood sample obtain . Subjects agree abstain consume alcohol /alcoholic beverage least 24 hour prior dose throughout study period last blood sample obtain . Subjects agree abstain use cigarettes tobacco product least 24 hour prior dose throughout study period last blood sample obtain . Subjects agree available entire study period ability understand communicate investigator staff . Use illicit drug alcohol could interfere completion study . Use counter prescribe drug unless approve principal investigator study physician . Use drug know inhibit/ induce CYP450 isozymes substrate CYP3A4 , CYP2D6 , CYP2C8 enzymes . ( use hormonal contraceptive permit except oral contraceptive ) Pregnant breast feeding . History acute chronic illness , diabetes , hypertension , CAD , psychiatric illness , renal hepatic impairment . Evidence acute illness . Family history congenital prolongation QTc interval condition know prolong QTc interval , cardiac arrhythmia , bradycardia severe heart disease History hypokalemia , hypomagnesemia hypercholesteremia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Herbal medicine</keyword>
	<keyword>African Potato</keyword>
	<keyword>Hypoxis obtusa</keyword>
	<keyword>Drug interaction</keyword>
	<keyword>HIV Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Healthy Subjects</keyword>
	<keyword>Anti-retroviral Agents</keyword>
	<keyword>Lopinavir</keyword>
	<keyword>Ritonavir</keyword>
</DOC>